Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Buchanan

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Bioinformatics (Oxford, England)|September 21, 2021
DLAB: deep learning methods for structure-based virtual screening of antibodiesConstantin Schneider, Andrew Buchanan, Bruck Taddese, et al.
Health & Social Care in the Community|January 17, 2018
Beyond mere pill taking: SMS reminders for HIV treatment adherence delivered to mobile phones of clients in a community support network in AustraliaLimin Mao, Andrew Buchanan, Horas Tze Hoo Wong, et al.
Drug Discovery Today|May 18, 2024
Best practices for machine learning in antibody discovery and developmentLeonard Wossnig, Norbert Furtmann, Andrew Buchanan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 2, 2012
Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactiveRomaldas Maciulaitis, Lucia D'Apote, Andrew Buchanan, et al.
Nature Communications|February 28, 2023
Cell surface protein aggregation triggers endocytosis to maintain plasma membrane proteostasisDavid Paul, Omer Stern, Yvonne Vallis, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Defining Regions in Multiregional Clinical Trials: An Analytical Approach to Considering Impact of Intrinsic and Extrinsic FactorsYoko Tanaka, Andrew Buchanan, Sarah Lipsius, et al.
Protein Engineering, Design & Selection : PEDS|September 4, 2012
Improved drug-like properties of therapeutic proteins by directed evolutionAndrew Buchanan, Franco Ferraro, Steven Rust, et al.
Plos One|January 6, 2010
Automated discovery of novel drug formulations using predictive iterated high throughput experimentationFilippo Caschera, Gianluca Gazzola, Mark A Bedau, et al.
Sexual Health|April 28, 2022
Sampling time for self-taking an oropharyngeal swab for gonorrhoea and chlamydia testingEric P F Chow, Christopher K Fairley, Kate Maddaford, et al.
Advances in Therapy|September 29, 2020
Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature ReviewElizabeth Leroux, Andrew Buchanan, Louise Lombard, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Bioinformatics (Oxford, England)|September 21, 2021
DLAB: deep learning methods for structure-based virtual screening of antibodiesConstantin Schneider, Andrew Buchanan, Bruck Taddese, et al.
Health & Social Care in the Community|January 17, 2018
Beyond mere pill taking: SMS reminders for HIV treatment adherence delivered to mobile phones of clients in a community support network in AustraliaLimin Mao, Andrew Buchanan, Horas Tze Hoo Wong, et al.
Drug Discovery Today|May 18, 2024
Best practices for machine learning in antibody discovery and developmentLeonard Wossnig, Norbert Furtmann, Andrew Buchanan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 2, 2012
Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactiveRomaldas Maciulaitis, Lucia D'Apote, Andrew Buchanan, et al.
Nature Communications|February 28, 2023
Cell surface protein aggregation triggers endocytosis to maintain plasma membrane proteostasisDavid Paul, Omer Stern, Yvonne Vallis, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Defining Regions in Multiregional Clinical Trials: An Analytical Approach to Considering Impact of Intrinsic and Extrinsic FactorsYoko Tanaka, Andrew Buchanan, Sarah Lipsius, et al.
Protein Engineering, Design & Selection : PEDS|September 4, 2012
Improved drug-like properties of therapeutic proteins by directed evolutionAndrew Buchanan, Franco Ferraro, Steven Rust, et al.
Plos One|January 6, 2010
Automated discovery of novel drug formulations using predictive iterated high throughput experimentationFilippo Caschera, Gianluca Gazzola, Mark A Bedau, et al.
Sexual Health|April 28, 2022
Sampling time for self-taking an oropharyngeal swab for gonorrhoea and chlamydia testingEric P F Chow, Christopher K Fairley, Kate Maddaford, et al.
Advances in Therapy|September 29, 2020
Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature ReviewElizabeth Leroux, Andrew Buchanan, Louise Lombard, et al.
Pageof 7